Immutep and Monash University Announce First Publication Detailing How Human LAG-3 Binds to ...
Findings published in Science Immunology resolve how human LAG-3 binds to its main ligand providing a better foundation for ...
technologynetworks17 小时
Study Sheds Light on New Ways for Immunotherapy to Better Target Cancer
Monash University-led research reveals the crystal structure of LAG-3 binding to HLA-II molecules, a breakthrough in cancer ...
Le Lézard1 小时
MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment ...
MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that the FDA has designated THIO for the ...